Approval of Amalgamation Scheme under Companies Act, 2013 for Efficiency and Profitability The Tribunal sanctioned the Scheme of Amalgamation between Vaid Die Casting Private Limited (Transferor Company) and Mega Fine Pharma Private Limited ...
Cases where this provision is explicitly mentioned in the judgment/order text; may not be exhaustive. To view the complete list of cases mentioning this section, Click here.
Provisions expressly mentioned in the judgment/order text.
Approval of Amalgamation Scheme under Companies Act, 2013 for Efficiency and Profitability
The Tribunal sanctioned the Scheme of Amalgamation between Vaid Die Casting Private Limited (Transferor Company) and Mega Fine Pharma Private Limited (Transferee Company) under sections 230-232 of the Companies Act, 2013. The Scheme aimed to combine operations for efficiency and profitability. The Tribunal found the Scheme compliant with Accounting Standards, addressed objections raised by regulatory bodies, including tax implications, and deemed it fair and reasonable. The Transferor Company was to be dissolved without winding up, with specific procedural requirements to be met by the Petitioner Companies. Interested parties could seek necessary directions based on the Tribunal's order.
Issues Involved: 1. Sanction of the Scheme of Amalgamation under sections 230-232 of the Companies Act, 2013. 2. Compliance with Accounting Standards. 3. Observations and objections raised by the Regional Director (RD) and Registrar of Companies (RoC). 4. Solvency Certificate requirement. 5. Main objects of the Transferor and Transferee Companies. 6. Financial position and revaluation of assets of the Transferor Company. 7. Tax implications of the Scheme. 8. Statutory compliances and objections. 9. Fairness and reasonableness of the Scheme.
Issue-wise Detailed Analysis:
1. Sanction of the Scheme of Amalgamation: The petition sought the Tribunal's sanction under sections 230-232 of the Companies Act, 2013 for the Scheme of Amalgamation between Vaid Die Casting Private Limited (Transferor Company) and Mega Fine Pharma Private Limited (Transferee Company). The Scheme aimed to combine operations to benefit from economies of scale, rationalize entities, and enhance profitability.
2. Compliance with Accounting Standards: The RD highlighted the necessity for the Transferee Company to comply with AS-14 (IND-AS-103) and other applicable Accounting Standards such as AS-5 (IND-AS-8). The Petitioner Companies undertook to comply with these standards, noting that IND AS-103 and IND AS-8 were not applicable for the financial year 2016-2017.
3. Observations and Objections Raised by RD and RoC: The RD's report included several observations: - Compliance with AS-14 and other standards. - Appointed Date to be maintained as 1st April 2017. - Notice to Income Tax Department. - Tax implications subject to Income Tax Authority's decision. - Submission of a certificate for accounting treatment conformity. - Objections based on the RoC's report.
The Petitioner Companies addressed these observations satisfactorily, and the RD accepted most replies in a supplementary report.
4. Solvency Certificate Requirement: The RoC required a Solvency Certificate under section 233 (1)(c) read with Section 233 (12) of the Companies Act, 2013. The Petitioner Companies submitted the requisite Solvency Certificates.
5. Main Objects of the Transferor and Transferee Companies: The RoC objected to the amalgamation due to differing main objects of the companies. The Transferee Company undertook to amend its Memorandum of Association to incorporate the Transferor Company's objects, resolving this objection.
6. Financial Position and Revaluation of Assets of the Transferor Company: The RoC raised concerns about the Transferor Company crediting Rs. 1.16 crore directly to the Reserve without recognizing it as income. The Petitioner Companies argued that the revaluation was in accordance with AS-10, which allows crediting revaluation reserves directly to the owner's interests. The Tribunal found merit in this argument, noting that the revaluation was not dubious.
7. Tax Implications of the Scheme: The Tribunal clarified that the Income Tax Department could independently determine any tax liability arising from the transaction. The sanction of the Scheme would not impede such determination.
8. Statutory Compliances and Objections: The Petitioner Companies complied with all statutory requirements and addressed objections raised by the RD and RoC. The Tribunal found the clarifications and undertakings satisfactory.
9. Fairness and Reasonableness of the Scheme: The Tribunal concluded that the Scheme was fair, reasonable, and not violative of any law or public policy. No objections were raised by any party.
Judgment: The Tribunal sanctioned the Scheme with the Appointed Date fixed as 1st April 2017. The Transferor Company was to be dissolved without winding up. The Petitioner Companies were directed to comply with specific procedural requirements, including lodging copies of the order with relevant authorities and paying costs to the RD and Official Liquidator. The Tribunal's order was to be acted upon by all concerned regulatory authorities, and any interested party could apply for necessary directions.
Full Summary is available for active users!
Note: It is a system-generated summary and is for quick reference only.